The list of recent interview articles
Archive Interviews before 2025
Issue 1039: April 11, 2025
William Korinek, Ph.D. and Theodore Liston, Ph.D., CEO and Co-Founder of Astrocyte Pharmaceuticals and Vice-President of Research at Astrocyte Pharmaceuticals, on Pioneering a New Treatment for Injuries to the Brain by Targeting Astrocytes.
Issue 1037: March 28, 2025
W. David Arnold, M.D., Executive Director of the NextGen Precision Health initiative, Professor of Physical Medicine and Rehabilitation, Neurology and Medical Pharmacology and Physiology, University of Missouri, on developing a novel potential therapy for age-related weakness.
Issue 1034: February 28, 2025
Etienne Sibille, Ph.D. and Thomas Prevot, Ph.D., Scientific Director of the Neurobiology of Depression and Aging Program and the Campbell Chair at the Campbell Family Mental Health Research Institute of the Centre for Addiction and Mental Health and Staff Scientist at the Neurobiology of Depression and Aging Program at the Campbell Family Mental Health Research Institute of the Centre for Addiction and Mental Health, on developing a breakthrough drug with the potential to treat cognitive dysfunction in Alzheimer’s disease.
Issue 1033: February 21, 2025
Nadav Ahituv, Ph.D., Professor, Department of Bioengineering and Therapeutic Sciences, Director, Institute for Human Genetics, University of California San Francisco, on engineering fat cells to suppress tumor cells.
Issue 1031: February 7, 2025
Sherri Oberg, CEO and Co-Founder of Particles for Humanity, on developing a solution for the historic issue of instability in vitamin A to treat vitamin A deficiency in areas with high unmet need.
Issue 1030: January 31, 2025
Flaura Winston, M.D., Ph.D., Director of the Innovation Ecosystem Initiative, Children’s Hospital of Philadelphia, on bringing an entrepreneurial perspective to academia.
Issue 1029: January 24, 2025
Evonne Sepsis, Founder and Managing Partner of ESC Advisors, on getting biotech clinical assets to a value inflection point.
Issue 1028: January 17, 2025
B. Frank Gupton, Ph.D., Chief Executive Officer, Medicines for All Institute at Virginia Commonwealth University, on eliminating waste and inefficiency in the drug manufacturing process.